In vitro ヒトiPS細胞由来ニューロンを用いたAIによる痙攣毒性予測-HESI NeuTox Pilot study-

DOI Web Site オープンアクセス
  • 松田 直毅
    東北工業大・院工・電子工学
  • 小田原 あおい
    東北工業大・院工・電子工学 東北大学材料科学高等研究所 日本学術振興会
  • 鈴木 郁郎
    東北工業大・院工・電子工学 ヒトiPS細胞応用安全性評価コンソーシアム Health and Environmental Sciences Institute 日本医療研究開発機構

書誌事項

タイトル別名
  • Assessment of seizure liability in human iPSC-derived neurons using AI-HESI NeuTox Pilot study-

説明

<p>Micro-electrode array (MEA) assay using human iPSC-derived neurons are expected to one of in vitro assays to predict the toxicity and predict the mechanism of action of drugs. MEA subteam of NeuTox Committee in Health and Environmental Science Institute (HESI) have started the pilot study for the prediction of seizure liability of drugs. In this study, we aimed to develop an analytical method enabling the evaluation of toxicity of convulsants using deep learning. Human iPSC-derived cortical neurons and astrocytes were cultured on 24-wells MEA plate for extracellular recording using MED64 Presto. HESI twelve compounds were tested at 5 concentrations for each compound (n&gt;6). We firstly had artificial intelligence (AI) learned the data of convulsants and the data of non-convulsants. Next this AI predicted the Toxicity of the data not used for learning. The toxicity probability of unlearned sample data was 90% or more, and the toxicity probability of the unlearned convulsants was also 80% or more. In addition, the negative probability of non-convulsants was more than 80%. These results indicated that this AI analysis method is useful for predicting the convulsion toxicity using hiPSC-derived neurons.</p>

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ